TABLE 2.
ELISA and PEG-IC IgG and IgM results
| Category | Serum ELISA result | All samplesa
|
First sample onlyb
|
||
|---|---|---|---|---|---|
| PEG-IC IgG ELISA (no. positive/serum IgG ELISA) | PEG-IC IgM ELISA (no. positive/serum IgM ELISA) | PEG-IC IgG ELISA (no. positive/serum IgG ELISA) | PEG-IC IgM ELISA (no. positive/serum IgM ELISA) | ||
| All samples | Negative | 11/44 | 7/42 | 6/35 | 5/28 |
| Positive | 54/57 | 21/33 | 35/38 | 12/19 | |
| Indeterminatec | 6/11 | 1/2 | 5/10 | 0/1 | |
| PTLDS | Negative | 7/11 | 3/13 | 3/5 | 2/5 |
| Positive | 26/26 | 10/16 | 14/14 | 4/7 | |
| Indeterminatec | 2/2 | 1/2 | 0/1 | ||
| Early LD | Negative | 1/3 | 0/3 | 0/2 | |
| Positive | 1/2 | 3/4 | 2/3 | ||
| Indeterminatec | 0/1 | 0/0 | 0/0 | ||
| All Lymed | Negative | 10/18 | 4/21 | 5/9 | 2/8 |
| Positive | 40/41 | 19/29 | 21/22 | 10/15 | |
| Indeterminatec | 3/4 | 1/2 | 2/3 | 0/1 | |
| OspA vaccinees | Negative | 1/9 | 3/11 | 3/11 | |
| Positive | 14/16 | 2/2 | 2/2 | ||
| Indeterminatec | 3/6 | 0/0 | 0/0 | ||
| Healthy volunteers | Negative | 0/17 | 0/10 | 0/9 | |
| Positive | 0/0 | 0/2 | 0/2 | ||
| Indeterminatec | 0/1 | 0/0 | 0/0 | ||
a
Includes all results.
b
Uses only the first complete sample pair per patient or control. Where there are no data in these columns, they are the same as those indicated in the “All samples” column.
c
Refers to samples with equal numbers of positive and negative results (in cases where the sample was tested more than once).
d
Refers to all patients with Lyme disease and includes posttreatment Lyme disease syndrome, early Lyme disease, Lyme arthritis, and neurologic Lyme disease patients.